¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Infarction, acute myocardial"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • acute abdomen
    ±Þ¼ºº¹Áõ
  • acute acalculous cholecystitis
    ±Þ¼º¹«°á¼®¾µ°³(ÁÖ¸Ó´Ï)¿°, ±Þ¼º¹«°á¼®´ã³¶¿°
  • acute appendicitis
    ±Þ¼ºÃæ¼ö¿°, ±Þ¼º¸·Ã¢ÀÚ²¿¸®¿°
  • acute brain syndrome
    ±Þ¼º³úÁõÈıº
  • acute catarrhal laryngitis
    ±Þ¼ºÄ«Å¸¸£Èĵο°
  • acute cholecystitis
    ±Þ¼º¾µ°³(ÁÖ¸Ó´Ï)¿°, ±Þ¼º´ã³¶¿°
  • acute confusional state
    ±Þ¼ºÈ¥µ·»óÅÂ
  • acute delusional psychosis
    ±Þ¼º¸Á»óÁ¤½Åº´
  • acute disseminated encephalitis
    ±Þ¼ºÆÄÁ¾³ú¿°
  • acute disseminated encephalomyelitis
    ±Þ¼ºÆÄÁ¾³úô¼ö¿°
  • acute epiglottitis
    ±Þ¼ºÈĵΰ³¿°
  • acute exposure
    ±Þ¼º³ëÃâ
  • acute fulminating meningococcemia
    ±Þ¼ºÀü°Ý¼ö¸·¾Ë±ÕÇ÷Áõ
  • acute hemolytic transfusion reaction
    ±Þ¼º¿ëÇ÷¼º¼öÇ÷¹ÝÀÀ
  • acute hepatitis
    ±Þ¼º°£¿°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • myocardial stimulant
    ½É±ÙÀÚ±ØÁ¦, °­½ÉÁ¦
  • myocardial perfusion scintigraphy
    ½É±ÙÁÖ»ç¼ú, ½ÉÀå±ÙÀ°¼¶±¤Á¶¿µ¼ú
  • acute
    ±Þ¼º-
  • acute exposure
    ±Þ¼ºÇÇÆø, ±Þ¼º³ëÃâ
  • acute abdomen
    ±Þ¼ºº¹Áõ
  • acute anxiety neurosis
    ±Þ¼ººÒ¾È½Å°æÁõ
  • acute brain syndrome
    ±Þ¼º³úÁõÈıº
  • acute catarrhal laryngitis
    ±Þ¼ºÄ«Å¸¸£Èĵο°
  • acute confusional state
    ±Þ¼ºÈ¥µ·»óÅÂ
  • acute delusional psychosis
    ±Þ¼º¸Á»óÁ¤½Åº´
  • acute disseminated encephalitis
    ±Þ¼ºÆÄÁ¾³ú¿°
  • acute fulminating meningococcemia
    ±Þ¼ºÀü°Ý¼ö¸·¾Ë±ÕÇ÷Áõ
  • acute hemolytic transfusion reaction
    ±Þ¼º¿ëÇ÷¼öÇ÷¹ÝÀÀ
  • acute idiopathic polyneuritis
    ±Þ¼ºÆ¯¹ß´Ù¹ß½Å°æ¿°, ±Þ¼ºÆ¯¹ß¿©·¯½Å°æ¿°
  • acute infectious disease
    ±Þ¼º°¨¿°º´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • acute and late normal tissue effects
    Á¤»óÁ¶Á÷ ±Þ¼º¿µÇâ, Á¤»óÁ¶Á÷ ¸¸¼º ¿µÇâ
  • acute anterior poliomyelitis
    ±Þ¼ºÀü°¢¼ºÈ¸¹é¼ö¿°, Æú¸®¿À
  • acute anterior poliomyelitis =infantile par aly sis
    ±Þ¼º ȸ¹éô¼ö¿°(ÐáàõüéÛÜô±âÐæú).
  • acute anxiety neurosis
    ±Þ¼º ºÒ¾È½Å°æÁõ (¡­ÝÕäÌãêÌèñø).
  • acute aortitis
    ±Þ¼º ´ëµ¿¸Æ¿°(¡­´ëµ¿¸Æ¿°).
  • acute aortitis
    ±Þ¼º ´ëµ¿¸Æ¿°(¡­ÓÞÔÑØææú).
  • acute apical periodontitis
    ±Þ¼º ±Ù÷¼º Ä¡ÁÖ¿°(¡­ÐÆôÓàõöÍñ²æú).
  • acute appendicitis
    ±Þ¼º Ãæ¼ö¿°(¡­Ãæ¼ö¿°).
  • acute appendicitis
    ±Þ¼ºÃæ¼ö¿°.
  • acute arthritis
    ±Þ¼º °üÀý¿°(ÐáàõÎ¼ï½æú).
  • acute ascending myelitis
    ±Þ¼º »óÇà(¼º) ô¼ö¿°(¡­ß¾ú¼àõô±âÐæú).
  • acute ascending paralysis<³ª> p. ascendens acu ta
    ±Þ¼º »óÇà(¼º) ¸¶ºñ(¡­ß¾ú¼àõ Ýö).
  • acute ataxia
    ±Þ¼º ¿îµ¿½ÇÁ¶(¡­ê¡ÔÑã÷ðà).
  • acute auditory hallucinosis
    ±Þ¼º ȯûÁõ
  • acute bacterial arthritis
    ±Þ¼º ¼¼±Õ¼º °üÀý¿°(Ðáàõá¬Ð¶àõÎ¼ï½æú).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • infarction
    °æ»ö(Áõ)(ÌÛßáñø).
  • infarction
    °æ»öÁõ(ÌÛßáñø)
  • infarction pain
    °æ»öÅë(ÌÛßá÷Ô).
  • infarction,red
    Àû»ö(°æ»ö)(îåßä¡­)
  • infarction,white
    ¹é»ö(°æ»ö)(¹é»ö¡­)
  • interal infarction
    Ãøº®°æ»ö(ö°ÛúÌÛßá).
  • lacunar infarction
    ¿­°ø°æ»öÁõ.
  • liver infarction
    °£°æ»öÁõ(ÊÜÌÛßáñø).
  • lung infarction
    Æó°æ»öÁõ(øËÌãßáñø).
  • mesenteric infarction
    Àå°£¸·°æ»ö(íóÊàØ¯ÌÛßá).
  • mesenteric infarction
    Àå°£¸·°æ»ö(ÌÛßá)
  • mesenteric infarction
    Àå°£¸·°æ»ö(Àå°£¸·°æ»ö).
  • placental infarction
    Źݰæ»ö(¡­ÌÛßá).
  • placental infarction
    Źݰæ»ö(÷ÃÚïÌÛßá)
  • post-infarction syndrome
    »öÀüÈÄ ÁõÈıº
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
SMI Self-Motivation Inventory; senior medical investigator; severe mental impairment; silent myocardial ...
AML acute monocytic leukemia; acute mucosal lesion; acute myeloblastic leukemia; acute myelocytic leukem...
ACI acceleration index; acoustic comfort index; acute cardiac ischemia; acute coronary infarction; acute...
AP accessory pathway; accounts payable; acid phosphatase; acinar parenchyma; action potential; active p...
PI first meiotic prophase; isoelectric point; pacing impulse; package insert; pancreatic insufficiency;...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
AMI Acute myocardial infarct
AMI acute myocardial ischaemia
BIP Bezafibrate Infarction Prevention
CI Cerebral infarction
LI Lacunar infarction
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute abdomenitis
    ±Þ¼º º¹Áõ
  • acute alcoholism
    ±Þ¼º ¾ËÄÚ¿Ã Áßµ¶, ±Þ¼º ¾ËÄÚ¿Ã Áßµ¶Áõ£©¾ËÄÝÀÇ ¼·Ãë·Î ÀÎÇØ¼­ »ýü°¡ Á¤½ÅÀû, ½ÅüÀû ¿µÇâÀ» ¹Þ°í ÁÖ·Î Àϰú¼ºÀ¸·Î ÀǽÄÀå¾Ö°¡ »ý±â´Â °Í.

    acute allergic reaction (±Þ¼º °ú¹Î¼º ¹ÝÀÀ

  • acute alveolar injury
    ±Þ¼º ÆóÆ÷ ¼Õ»ó
    ±Þ¼º È£Èí°ï¶õ ÁõÈıºÀÇ ´Ù¸¥ À̸§.
  • acute anxiety neurosis
    ±Þ¼º ºÒ¾È½Å°æÁõ
  • acute apical abscess
    ±Þ¼º Ä¡±Ù´Ü ³ó¾ç
    µ¿ÀǾî=acute alveolar abscess.
  • acute appendicitis
    ±Þ¼º Ãæ¼ö¿°
    1. Ãæ¼ö¿° ȯÀÚÀÇ 50-80%¿¡¼­ ºÐ¼®
  • acute ascending paralysis
    ±Þ¼º »óÇà ¸¶ºñ, ±Þ¼º »óÇ༺ ¸¶ºñ
  • acute ataxia
    ±Þ¼º ¿îµ¿½ÇÁ¶
    ±ÙÀ° »óÈ£ÇùÁ¶°¡ °á¿©µÇ°Å³ª ±ÙÀ°±â´ÉÀÌ ºÒ±ÔÄ¢ÇÏ¿© ¿îµ¿±â´ÉÀÌ »ó½ÇµÇ´Â °Í.
  • acute atrophic candidiasis
    ±Þ¼º À§Ã༺ ĵµð´ÙÁõ
    ±Þ¼º À§Ã༺ ĵµð´ÙÁõÀÇ º´¼Ò´Â ĵµð´Ù °¨¿°ÀÇ ¶Ç ´Ù¸¥ ÇüÅ·μ­ ÈçÇÑ °ÍÀº ¾Æ´Ï´Ù. ÀÌ º´¼Ò´Â ¹Ýµå½Ã µ¿ÀÏ ÇüÅÂÀÇ È¯ÀÚ Áï ±Þ¼º À§¸·¼º ĵµð´ÙÁõÀ¸·Î ÁøÇàµÇ±â ½¬¿î ȯÀÚ¿¡¼­ ³ªÅ¸³­´Ù. ¶Ç ±¤¹üÀ§ Ç×»ýÁ¦ ½ºÅ×·ÎÀ̵å Á¦Á¦ ¶Ç´Â ¸é¿ª ¾ïÁ¦Á¦¸¦ Åõ¿© ¹Þ´Â ȯÀÚ¿¡¼­µµ ³ªÅ¸³­´Ù. Á¶Á÷ Ç¥º»À» º¸¸é Ç¥ÃþºÎ¿¡ ¼Ò¼öÀÇ ±Õ»ç¸¦ °¡Áö´Â À§Ã༺ »óÇǰ¡ ³ªÅ¸³ª°í °íÀ¯ Ãþ¿¡¼­´Â ´ë°³ °æ¹ÌÇÑ ±Þ¼º ¿°Áõ¼º ħÀ±ÀÌ ³ªÅ¸³ª¸ç Ç÷°üÀÇ ¼ö°¡ Áõ°¡ÇÑ´Ù. ĵµð´ÙÁõ ½Ã ³ªÅ¸³ª´Â º´¼Ò´Â ´Ï½ºÅ¸Æ¾ ±¸°­ Çöʾ×À̳ª ±¸°­ Á¤Á¦·Îµµ »ç¿ëµÇ´Â ´Ï½ºÅ¸Æ¾ Á¤Á¦¸¦ »ç¿ëÇØµµ Àß Ä¡À¯µÈ´Ù.
  • acute auditory hallucinosis
    ±Þ¼º ȯûÁõ
  • acute bacterial endocarditis
    ±Þ¼º ¼¼±Õ¼º ½É³»¸·¿°
  • acute bacterial meningitis
    ±Þ¼º ¼¼±Õ¼º ³ú¸·¿°
  • acute bacterial sialadenitis
    ±Þ¼º ¼¼±Õ¼º Ÿ¾×¼±¿°
  • acute bleeding
    ±Þ¼º ÃâÇ÷
  • acute brain disorder
    ±Þ¼º ³úÀå¾Ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
myocardial contusion A bruise to the heart muscle, usually caused by a blunt force applied to the anterior thorax (motor vehicle accident). Commonly seen in association with a rib or sternum fracture. Complications include cardiac arrhythmias and death.
(27 Sep 1997)
myocardial depressant factor A low molecular weight peptide of about 800-1000 having a negative inotropic effect. It is released into the circulation during experimental haemorrhagic pancreatitis, severe ischemia, and postoligaemic shock.
(12 Dec 1998)
myocardial diseases Diseases of the myocardium.
(12 Dec 1998)
myocardial infarct imaging <radiology> Tc-99m pyrophosphate (PYP) 20 mCi, peak abnormality 2-3 days, often falsely negative before 2 days, abnormal for 7-10 days, mechanism: calcium influx into ischemic cells, PYP incorporated into crystalline structure, analogous to hydroxyapatite see: nuclear cardiology
(12 Dec 1998)
myocardial insufficiency A condition where there is ineffective pumping of the heart leading to an accumulation of fluid in the lungs. Typical symptoms include shortness of breath with exertion, difficulty breathing when lying flat and leg or ankle swelling. Causes include chronic hypertension, cardiomyopathy and myocardial infarction.
(27 Sep 1997)
myocardial ischemia A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (coronary arteriosclerosis), to obstruction by a thrombus (coronary thrombosis), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (myocardial infarction).
(12 Dec 1998)
myocardial necrosis Irreversible destruction of myocardial (heart muscle) cells.
(27 Sep 1997)
myocardial perfusion imaging <radiology> (thallium scanning) thallium (Tl) 201, acts as potassium analog, dose 2.0 - 3.0 mCi at peak exercise, 4% of injected dose reaches myocardium, imaging: exercise (1-5 min), redistribution (3-4 hrs), views: anterior, LAO 45', left lateral, interpretation: normal, reversible abnormalitymost likely to be exercise-induced ischemia, nonreversible abnormalitymost likely to be prior myocardial infarction, reverse redistribution most likely to be normal areas wash out faster, lung activity most likely to be LV failure during exercise see also: dipyridamole test, nuclear cardiology
(12 Dec 1998)
myocardial reperfusion Generally, restoration of blood supply to heart tissue which is ischemic due to decrease in normal blood supply. The decrease may result from any source including atherosclerotic obstruction, narrowing of the artery, or surgical clamping. Reperfusion can be induced to treat ischemia. Methods include chemical dissolution of an occluding thrombus, administration of vasodilator drugs, angioplasty, catheterization, and artery bypass graft surgery. However, it is thought that reperfusion can itself further damage the ischemic tissue, causing myocardial reperfusion injury.
(12 Dec 1998)
myocardial reperfusion injury Functional, metabolic, or structural changes in ischemic heart muscle thought to result from reperfusion to the ischemic areas. Changes can be fatal to muscle cells and may include oedema with explosive cell swelling and disintegration, sarcolemma disruption, fragmentation of mitochondria, contraction band necrosis, enzyme washout, and calcium overload. Other damage may include haemorrhage and ventricular arrhythmias. One possible mechanism of damage is thought to be oxygen free radicals. Treatment currently includes the introduction of scavengers of oxygen free radicals, and injury is thought to be prevented by warm blood cardioplegic infusion prior to reperfusion.
(12 Dec 1998)
myocardial revascularization The restoration of blood supply to the myocardium.
(12 Dec 1998)
myocardial rigor mortis Irreversible contraction of the left ventricle of the heart as a complication seen in the early period of cardiopulmonary bypass and now avoided by appropriate cardioplegic solutions.
Synonym: myocardial rigor mortis, stone heart.
(05 Mar 2000)
myocardial stunning Prolonged dysfunction of the myocardium after a brief episode of severe ischemia, with gradual return of contractile activity. It occurs frequently, both in the experimental laboratory and in clinical medicine. Since stunned myocardium occurs adjacent to necrotic tissue after prolonged coronary occlusion, many myocardial infarcts may be a mixture of necrotic and stunned tissue.
(12 Dec 1998)
ischemic preconditioning, myocardial Exposure of myocardial tissue to brief, repeated periods of vascular occlusion in order to render the myocardium resistant to the deleterious effects of ischemia or reperfusion. The period of pre-exposure and the number of times the tissue is exposed to ischemia and reperfusion vary, the average being 3 to 5 minutes.
(12 Dec 1998)
abdomen, acute Clinical syndrome characterised by abdominal pain of great severity associated with other symptoms and signs, usually those of acute peritonitis, which might well be the result of a ruptured abdominal viscus or a similar abdominal catastrophe requiring urgent surgical operation.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á